{"id":"W2057495794","doi":"10.1517/13543784.2011.565329","title":"Brivanib alaninate for cancer","year":2011,"lang":"en","type":"review","venue":"Expert Opinion on Investigational Drugs","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Cetuximab; Medicine; Pharmacodynamics; Pharmacology; Cancer; Regorafenib; Angiogenesis; Colorectal cancer; Pharmacokinetics; Oncology; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002606088,0.0006111839,0.000581811,0.001063706,0.0002552088,0.0006860034,0.000604391,0.00105934,0.02348419],"category_scores_gemma":[0.0003214451,0.0001353713,0.0003576166,0.0008302602,0.0002571996,0.0005533322,0.000549705,0.001336466,0.02071229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005144167,"about_ca_system_score_gemma":0.0005591345,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000599663,"about_ca_topic_score_gemma":0.001366601,"domain_scores_codex":[0.9998626,0.00002409397,0.00001082419,0.00002799762,0.00005341964,0.00002113895],"domain_scores_gemma":[0.9999142,0.00001755599,0.00002083299,0.000004144548,0.0000224307,0.0000208873],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001585448,0.00005030187,0.00007171223,0.003175507,0.00003353567,0.0003412135,0.00002510841,0.000125538,0.003183956,0.003089533,0.1119247,0.8778202],"study_design_scores_gemma":[0.00005546846,0.00007876856,0.0002160818,0.0004726875,0.0000172664,0.001239881,0.000007178648,0.00003203543,0.0008598668,0.000659858,0.9963551,0.000005908374],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0008614184,0.9499002,0.0006685265,0.003749992,0.002341228,0.00005129792,0.0002488008,0.0001444394,0.04203412],"genre_scores_gemma":[0.01182924,0.919319,0.0008882011,0.003970467,0.002450527,0.00008187187,0.0008192275,0.00002840409,0.06061308],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02348419,"threshold_uncertainty_score":0.0785625,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1165598438133721,"score_gpt":0.4131320326980932,"score_spread":0.2965721888847211,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}